Introduction of Ivacaftor/Lumacaftor in Children With Cystic Fibrosis Homozygous for F508del in the Netherlands: A Nationwide Real‐Life Study

Lum/iva was generally well tolerated in a real-life, nationwide pediatric cohort. The efficacy of lum/iva was comparable to phase 3 studies in children. LCI and BA analysis as markers of small airway and structural lung disease showed significant improvement which indicates the importance of these parameters to evaluate treatment effects of CF modulators in children.

Authors

Institutions

Publication Details

Journal
Pediatric Pulmonology
Published
2025-01-01
DOI
https://doi.org/10.1002/ppul.27473
Citations
2
Primary Topic
Cystic Fibrosis Research Advances
Type
article
Field-Weighted Citation Impact
3.04

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Introduction of Ivacaftor/Lumacaftor in Children With Cystic Fibrosis Homozygous for F508del in the Netherlands: A Nationwide Real‐Life Study

Michiel Bannier, Yuxin Chen, Marianne Nuijsink, Judith M. Vonk et al.
2 citations
Pediatric Pulmonology
Cystic Fibrosis Research Advances
3.04
article

Introduction of Ivacaftor/Lumacaftor in Children With Cystic Fibrosis Homozygous for F508del in the Netherlands: A Nationwide Real‐Life Study

Michiel Bannier, Yuxin Chen, Marianne Nuijsink, Judith M. Vonk, Annelies M. Zwitserloot, Gerard H. Koppelman, Suzanne W. J. Terheggen‐Lagro, Shima Aziz, Hettie M. Janssens, Peter Merkus, Kate Groot, Brigitte W.M. Willemse, Harm A.W.M. Tiddens, D. D. Zomer‐ van Ommen
article en
2 citations

Abstract

Lum/iva was generally well tolerated in a real-life, nationwide pediatric cohort. The efficacy of lum/iva was comparable to phase 3 studies in children. LCI and BA analysis as markers of small airway and structural lung disease showed significant improvement which indicates the importance of these parameters to evaluate treatment effects of CF modulators in children.

Pediatric PulmonologyVol. 60(1)
University Medical Center Groningen (NL), Radboud University Nijmegen (NL), University of Groningen (NL), Utrecht University (NL), Erasmus MC (NL), Radboud University Medical Center (NL), University Medical Center Utrecht (NL), Maastricht University (NL), Nederlandse Cystic Fibrosis Stichting (NL), Emma Kinderziekenhuis (NL), Haga Hospital (NL), Amsterdam University Medical Centers (NL), Wilhelmina Children's Hospital (NL)
Vertex Pharmaceuticals
Responsible consumption and production
Openalex Percentile: Top 12%
Cystic Fibrosis Research Advances
3.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.